{"id":"W2886451501","doi":"10.1080/14656566.2018.1502270","title":"Choosing oral drug therapy for overactive bladder in older people","year":2018,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Capital District Health Authority; University of Alberta","funders":"","keywords":"Mirabegron; Medicine; Overactive bladder; Tolerability; Anticholinergic; Oxybutynin; Polypharmacy; Older people; Adverse effect; Clinical trial; Solifenacin; Urinary incontinence; Intensive care medicine; Tolterodine; Pharmacotherapy; Alternative medicine; Internal medicine; Urology; Gerontology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453527,0.0002037037,0.0009344296,0.0004101168,0.0003069036,0.001050379,0.0004535622,0.001730956,0.01045442],"category_scores_gemma":[0.006299912,0.00008833029,0.000775888,0.0004406498,0.0003976314,0.0009926925,0.0005295181,0.001262956,0.002163229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004801047,"about_ca_system_score_gemma":0.001322025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00130875,"about_ca_topic_score_gemma":0.003911586,"domain_scores_codex":[0.998847,0.0004444765,0.0001887917,0.0001298777,0.0003279856,0.00006176187],"domain_scores_gemma":[0.9977254,0.001026095,0.0005730271,0.00003951395,0.0004372378,0.0001987452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003932022,0.0001329618,0.007404345,0.0134503,0.0003471305,0.0004687374,0.0002447269,0.0001030163,0.0008260624,0.002889491,0.1212781,0.8524618],"study_design_scores_gemma":[0.0008872499,0.0008062947,0.02207116,0.03953853,0.001141134,0.003741389,0.0009885329,0.0003765992,0.001341689,0.01086616,0.9181488,0.00009254379],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009086518,0.8650669,0.001693195,0.09819525,0.004937988,0.0001211495,0.0005734849,0.00004982349,0.02027569],"genre_scores_gemma":[0.07931053,0.8395802,0.004989794,0.05776947,0.009140234,0.0001748109,0.0006257344,0.00002660565,0.008382635],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01045442,"threshold_uncertainty_score":0.0349735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05773820357586884,"score_gpt":0.4449890274900204,"score_spread":0.3872508239141516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}